Medication consumption profile in the emergency department from the Abidjan Cardiology Institute – Ivory Coast

Abstract

The availability of treatment methods in emergencies cardiovascular, linked largely by medications, thus allows adequate management patients. This study is part of the objective of evaluating the consumption profile of medications to the emergency department of the Abidjan Cardiology Institute in order to identify the classes available and essential pharmacotherapeutics. The method used in this work was retrospective and descriptive. It made it possible to categorize the drugs prescribed in the emergency room of the Abidjan Cardiology Institute based on patient prescriptions received during the study period defined from August 2022 to April 2023. These Prescriptions were subject to inclusion and non-inclusion criteria. Collected using a survey sheet, the data collected through the prescriptions included information on the ATC classification of drugs, the international nonproprietary name, the daily dose and the number of daily intake. Results were expressed as mean and relative frequency. From the 1205 prescriptions recorded on 1008 patients, we note that each patient received an average of 1.19 prescriptions per day containing an average of 3.08 lines of prescriptions by orders. Seven (7) ATC classes were observed, the main ones being the classes of cardiovascular system medications (54%), blood medications (14%) and medications anti-infectives for systemic use (13%). The uses of these classes were justified in emergency rooms the Abidjan Cardiology Institute. The average daily doses and intakes were consistent with the Vidal 2022® recommendations. The cardiovascular system drug class as well as other classes have been identified as essential to the proper functioning of the Heart Institute's emergency department from Abidjan.